Insertional Mutagenesis Strategies in Cancer Genetics [Hardcover]

The goal of this work is summarize the contribution that insertional mutagenesis has made to our understanding of cancer. A variety of insertional mutagens are presented that have been used to study a variety of tumor types in several model organisms. In addition, the impact of insertional mutagenesis in several gene therapy trials is discussed along with strategies to avoid such complications in future clinical trials.

Summarizing the contribution that insertional mutagenesis has made to our understanding of cancer, this volume presents various insertional mutagens as well as their impact in gene therapy trials. The book also recommends strategies for future clinical trials.

Chapter 1:IntroductionAuthor: Anton Berns (Netherlands Cancer Institute)Chapter 2:Retroviral mutagenesis in mouse leukemia/lymphomaAuthor: David Largaespada, Ph.D. (University of Minnesota)Chapter 3:MMTV models of breast cancerAuthor: John Hilkens (NKI)Chapter 4:Retroviral mutagenesis in other organismsAuthor: Michael Dvorak (Inst. Of Molecular Genetics, Prague, Czech Rep.)Chapter 5:Sleeping Beauty models of cancerAuthor: Adam J. Dupuy, Ph.D. (University of Iowa)Chapter 6:Insertional mutagenesis in gene therapy patientsAuthor: David Williams, M.D. (Cincinnati Childrens Hospital)Chapter 7:Bioinformatics of high throughput insertional mutagenesisAuthor: Keiko Akagi (NCI-Frederick)

Adam Dupuy, Ph.D., is an Assistant Professor at the Carver College of Medicine at the University of Iowa, and a rising star in the field of insertional mutagenesis; two of the last of his publications have been in Nature, and he was the lead author on one of these. Dr. Dupuy earned his B.A. at Central College in Pella, Iowar, went on to earn his Ph.D. at the University of Minnesota in the Program in Molecular, Cellular, Developmental Biology & Genetics, and did his Postdoctoral fellowship in the Mouse Cancer Genetics Program at the NCI-Frederick.

Over the past decades, insertiolCf